Gene · 3691
Papers3,577
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,577
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bufotalin Induces Oxidative Stress-Mediated Apoptosis by Blocking the ITGB4/FAK/ERK Pathway in Glioblastoma. | Antioxidants (Basel) | 2024 | 39456433 | PubTator, text mining | PubMed |
| YKL40/Integrin β4 Axis Induced by the Interaction between Cancer Cells and Tumor-Associated Macrophages Is Involved in the Progression of High-Grade Serous Ovarian Carcinoma. | Int J Mol Sci | 2024 | 39408927 | PubTator, text mining | PubMed |
| The single-cell transcriptome of mTECs and CD4+ thymocytes under adhesion revealed heterogeneity of mTECs and a network controlled by Aire and lncRNAs. | Front Immunol | 2024 | 39328409 | PubTator, text mining | PubMed |
| ITGB4-Related pyloric atresia without epidermolysis in two siblings. | Eur J Med Genet | 2024 | 39322060 | PubTator, text mining | PubMed |
| The Role of Serology in the Diagnosis of Ocular Predominant Mucous Membrane Pemphigoid and the Search for an Ocular-Specific Autoantigen. | Ocul Immunol Inflamm | 2024 | 39241171 | PubTator, text mining | PubMed |
| The mechanism of ITGB4 in tumor migration and invasion. | Front Oncol | 2024 | 39169946 | PubTator, text mining | PubMed |
| Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translation. | Oncogene | 2024 | 39154122 | PubTator, text mining | PubMed |
| Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas. | J Transl Med | 2024 | 39152432 | PubTator, text mining | PubMed |
| Trophoblast fusion in fetal growth restriction is inhibited by CTGF in a cell-cycle-dependent manner. | J Mol Histol | 2024 | 39122896 | PubTator, text mining | PubMed |
| Editorial: Mass spectrometry-based proteomics in drug discovery and development. | Front Med (Lausanne) | 2024 | 39109228 | PubTator, text mining | PubMed |
| Reconstruction of single-cell lineage trajectories and identification of diversity in fates during the epithelial-to-mesenchymal transition. | Proc Natl Acad Sci U S A | 2024 | 39093947 | PubTator, text mining | PubMed |
| Congenital pyloric atresia associated with epidermolysis bullosa junctionalis: a novel lethal variant. | BMJ Case Rep | 2024 | 39074943 | PubTator, text mining | PubMed |
| Lethal Carmi syndrome (junctional epidermolysis bullosa-pyloric atresia) with a novel and recurrent compound integrin beta 4 heterozygous mutation: A case report. | JAAD Case Rep | 2024 | 39070921 | PubTator, text mining | PubMed |
| Fibroblasts Promote Resistance to KRAS Silencing in Colorectal Cancer Cells. | Cancers (Basel) | 2024 | 39061234 | PubTator, text mining | PubMed |
| Multifunctional and bioinspired titanium surface with multilayer nanofilms for novel dental implant applications. | Front Chem | 2024 | 39036659 | PubTator, text mining | PubMed |
| IDH1-mutant metabolite D-2-hydroxyglutarate inhibits proliferation and sensitizes glioma to temozolomide via down-regulating ITGB4/PI3K/AKT. | Cell Death Discov | 2024 | 38982076 | PubTator, text mining | PubMed |
| [Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer]. | Zhonghua Fu Chan Ke Za Zhi | 2024 | 38951081 | PubTator, text mining | PubMed |
| Biophysical aspects of migrasome organelle formation and their diverse cellular functions. | Bioessays | 2024 | 38922978 | PubTator, text mining | PubMed |
| The association between integrin β4 overexpression and lymphovascular invasion in papillary thyroid cancer. | Endokrynol Pol | 2024 | 38887115 | PubTator, text mining | PubMed |
| Molecular autopsy by proxy: relevance for genetic counseling in rare genetic disorders. | Front Genet | 2024 | 38859940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3691/papers?page=8